PRKCD and infection: Statistical analysis showed that the RL treatment significantly reduced the phosphorylated PKCδ 15 min after infection (FCoV+/RL−, 1.32 ± 0.01 vs. FCoV+/RL+, 1.24 ± 0.02, p < 0.05) (Figure 2B).